Unambiguously, the VEGFR2 was shown to regulate protein kinase B (Akt)/mammalian target of rapamycin (mTOR)/ribosomal protein S6 kinase beta-1 (P70S6K) signalling pathway in PC-3 prostate cancer cell line [39]. Here, RPS6KB1 is linked to prostate carcinoma.